Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Scientific Reports|August 12, 2016
Mapping B-cell responses to Salmonella enterica serovars Typhimurium and Enteritidis in chickens for the discrimination of infected from vaccinated animalsIbrahim A Naqid, Jonathan P Owen, Ben C Maddison, et al.
JAMA Network Open|January 8, 2025
Mental Health Care Utilization and Prescription Rates Among Children, Adolescents, and Young Adults in FranceGuillaume Fond, Vanessa Pauly, Yann Brousse, et al.
Molecular Psychiatry|September 12, 2024
Safety of psychotropic medications in pregnancy: an umbrella reviewNicholas Fabiano, Stanley Wong, Arnav Gupta, et al.
Journal of Medicinal Chemistry|January 25, 2024
MicroCycle: An Integrated and Automated Platform to Accelerate Drug DiscoveryCara E Brocklehurst, Eva Altmann, Corentin Bon, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fractionElena Dragioti, Joaquim Radua, Marco Solmi, et al.
Molecular Psychiatry|June 24, 2024
Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella reviewNathan T M Huneke, Jay Amin, David S Baldwin, et al.
Molecular Psychiatry|September 8, 2023
Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease studySamuele Cortese, Minjin Song, Luis C Farhat, et al.
Molecular Psychiatry|June 29, 2022
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countriesMarco Solmi, Minjin Song, Dong Keon Yon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 8, 2025
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysisMikkel Højlund, Helin Y Kafali, Begüm Kırmızı, et al.
BMJ (Clinical Research Ed.)|November 26, 2025
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision makingCorentin J Gosling, Miguel Garcia-Argibay, Michele De Prisco, et al.
Pageof 10